PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24276455-6	2014	RESULTS: Sunitinib and cisplatin synergistically inhibited the growth of MZ-CRC-1 cells harboring the RET M918T activating mutation.	Sunitinib	9-18	ret proto-oncogene	Homo sapiens	102-105	
24276455-10	2014	CONCLUSIONS: Addition of cisplatin to sunitinib potentiates apoptotic cell death and has promising preclinical activity in MTCs harboring the RET M918T oncogene.	Sunitinib	38-47	ret proto-oncogene	Homo sapiens	142-145